Uniphos Enterprises Q2 FY27 results: net profit down 4.1% to ₹22.22 crore

How did Uniphos Enterprises perform in Q2 FY27?

Uniphos Enterprises reported standalone revenue of ₹0 crore in Q2 FY27, unchanged from both Q2 FY26 and Q1 FY27. Other income of ₹25.19 crore formed the quarter's income, against total expenses of ₹2.97 crore. The company reported a net profit of ₹22.22 crore and basic EPS of ₹3.19 for the July–September 2026 quarter.

Against the year-ago quarter, profit before tax and net profit both fell by ₹0.94 crore, or 4.1%, to ₹22.22 crore from ₹23.16 crore. Basic EPS fell by ₹0.14, or 4.2%, to ₹3.19 from ₹3.33. Against the previous quarter, profit before tax and net profit rose by ₹23.41 crore, and EPS moved from a loss of ₹0.17 to ₹3.19.

The company reported an EBITDA loss of ₹2.81 crore in Q2 FY27, wider than the ₹1.09 crore loss in Q2 FY26 and the ₹1.20 crore loss in Q1 FY27. No EBITDA margin figure was reported for any of the three quarters. The results are on a standalone basis; the filings did not give consolidated figures for the quarter.

What changed in Uniphos Enterprises' costs and profit?

Other income was the main contributor to the quarter's income, rising ₹0.76 crore, or 3.1%, to ₹25.19 crore from ₹24.43 crore in Q2 FY26, and ₹25.03 crore from ₹0.16 crore in Q1 FY27. Revenue from operations and cost of materials both remained at ₹0 crore, and finance costs were unchanged at no charge in the quarter.

Total expenses rose ₹1.70 crore, or 133.9%, to ₹2.97 crore from ₹1.27 crore in the year-ago quarter. Employee cost rose ₹1.96 crore, or 576.5%, to ₹2.30 crore from ₹0.34 crore. Other expenses fell ₹0.23 crore, or 30.7%, to ₹0.52 crore, while depreciation fell ₹0.01 crore, or 5.9%, to ₹0.16 crore.

There was no exceptional item in Q2 FY27, and tax was unchanged at no charge against Q2 FY26. With no revenue in the reported period, the filings did not state a reason for the higher employee cost or the increase in other income. Against Q1 FY27, total expenses rose ₹1.62 crore, or 120.0%, and employee cost rose ₹1.80 crore, or 360.0%.

How did the first half of FY27 go?

For the first half of FY27, total income was ₹25.36 crore, down ₹5.19 crore, or 17.0%, from ₹30.55 crore in H1 FY26. Revenue was ₹0 crore against ₹5.86 crore in the year-ago period, while the filings did not state a reason for the decline.

Profit before tax and net profit for H1 FY27 were ₹21.03 crore each, down ₹1.39 crore, or 6.2%, from ₹22.42 crore in H1 FY26. Basic EPS was ₹3.02, down ₹0.20, or 6.2%, from ₹3.22. The unaudited results were reviewed by the audit committee and approved by the board.

What do the balance sheet and cash flow show?

Total assets were ₹2,471.18 crore as on 30 September 2026, against ₹2,618.84 crore as on 31 March 2026. Total equity fell to ₹2,356.78 crore from ₹2,446.77 crore, and cash declined to ₹5.84 crore from ₹15.10 crore. The company had no borrowings at either date, and trade payables stood at ₹0.99 crore against ₹26.92 crore.

Operating cash flow for H1 FY27 was an outflow of ₹3.04 crore, compared with an outflow of ₹2.08 crore in H1 FY26. Investing cash flow was an inflow of ₹18.13 crore against ₹6.51 crore, and financing cash flow was an outflow of ₹24.34 crore against ₹3.48 crore. Capital expenditure was ₹0.03 crore in H1 FY27.

How has Uniphos Enterprises done over the last 8 quarters?

Revenue in the reported period was ₹0 crore, with operating revenue appearing in some quarters and not others across the last eight quarters. The highest revenue in the series was ₹72.9 crore in Q4 FY25, and the lowest was ₹0 crore in Q2 FY26, Q3 FY26, Q1 FY27 and Q2 FY27.

Net profit over the period was uneven, with a net loss of ₹1.86 crore in Q3 FY25, the deepest loss in the series, and a net profit of ₹23.16 crore in Q2 FY26, the highest. Profit was ₹22.22 crore in Q2 FY27, up from a net loss of ₹1.19 crore in Q1 FY27.

Reported EBITDA margin was lowest at -19.6% in Q3 FY25 and highest at -2.2% in Q4 FY25. No EBITDA margin was reported for Q2 FY26, Q3 FY26, Q1 FY27 or Q2 FY27. Revenue in the latest quarter remained at ₹0 crore.

What else did the company announce?

In its filing on 6 November 2026, the board said it had approved the unaudited financial results for the quarter and half year ended 30 September 2026, following a limited review by B S R & Co. LLP. The board also approved alteration of the Object Clause of the Memorandum of Association to incorporate real estate activities, covering development, redevelopment, project management, consultancy and property management.

The company said it owns a few land parcels with high potential of development given their strategic location, and proposed to develop them or explore other value-accretive options, including real estate opportunities beyond its existing land holdings. The board approved the appointment of Girish Goenka as chief executive officer with effect from 6 November 2026, and he will be a key managerial personnel.

The board also approved acquisition of 100% of the equity share capital of Mrugal Properties Limited, an unlisted public limited company, subject to all necessary statutory, regulatory, contractual and other approvals. The company said the target's objects are in line with its proposed realty development business and will be useful for project-specific realty development. The same-day filings did not announce a dividend or a fund raise.

How did other Trading - Chemicals companies do?

Six other Trading - Chemicals companies had filed for the quarter as on 6 November 2026, with a median revenue growth of 23.4%. Uniphos Enterprises reported no revenue for the quarter, so it did not match the pace of peers reporting growth.

Of the six peers compared, four reported higher profit. Five peers were compared on profit, and no peer was recorded as growing revenue faster than Uniphos Enterprises, since the company's revenue was unchanged at ₹0 crore.